Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Coronary Stents Market Revenue Growth On Track For A 8.3% CAGR Through 2030#_x000D_
The coronary stents market size has demonstrated robust growth in recent years. It is projected to expand from $11.9 billion in 2025 to $12.9 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This historical expansion can be attributed to the rising prevalence of coronary artery disease, an increasing number of percutaneous coronary intervention procedures, advancements in stent coating technologies, the expansion of interventional cardiology services, and improved clinical outcomes of coronary stenting._x000D_
_x000D_
The coronary stents market is forecast to achieve significant growth in the coming years, with its size expected to reach $17.76 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. This expansion during the projection period can be attributed to a number of factors, including an aging population facing higher cardiovascular risks, increasing demand for cardiac treatments that are minimally invasive, the growing adoption of next-generation stent technologies, a rising focus on the long-term healing of vessels and patient outcomes, and expanding access to cardiac care in emerging markets. Key trends foreseen in this forecast period involve the rising adoption of drug-eluting and dual therapy stents, an increasing preference for minimally invasive coronary interventions, a growing emphasis on reducing the risks of restenosis and thrombosis, an expansion in the usage of bioresorbable and biodegradable stents, and an increasing demand for advanced stent materials and designs._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Coronary Stents Market Demand Drivers: What’s Powering Industry Growth?#_x000D_
The increasing occurrence of cardiovascular diseases (CVDs) is projected to boost the expansion of the coronary stent market. CVDs encompass various heart and blood vessel disorders, such as coronary artery disease, heart failure, stroke, and hypertension. The rise in these diseases is linked to an aging global population and a higher incidence of risk factors like obesity, diabetes, inactive lifestyles, inadequate nutrition, and stress. Coronary stents are crucial in managing cardiovascular conditions by opening constricted or obstructed coronary arteries, thereby enhancing cardiac blood flow and lowering heart attack risks. For example, data from October 2024 by the Centers for Disease Control and Prevention, a US-based government agency, revealed that in 2023, cardiovascular disease was responsible for 919,032 fatalities, representing about one in every three deaths. Consequently, the growing incidence of cardiovascular diseases (CVDs) is fueling the expansion of the coronary stent market._x000D_
_x000D_
#Coronary Stents Market Segment Trends And Revenue Contributors#_x000D_
The coronary stents market covered in this report is segmented – _x000D_
_x000D_
1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents _x000D_
2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies_x000D_
3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer_x000D_
4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents_x000D_
5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses_x000D_
_x000D_
Subsegments:_x000D_
1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents _x000D_
2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents _x000D_
3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents _x000D_
4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents _x000D_
5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents _x000D_
6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents _x000D_
7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents _x000D_
8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents _x000D_
9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents_x000D_
_x000D_
_x000D_
#Coronary Stents Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_
Companies active in the coronary stent market are developing innovative products, such as drug-eluting stents, to lessen the requirement for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary devices coated with medication, designed to prevent the re-narrowing of arteries by gradually releasing drugs over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is distinguished by its enhanced design, a new delivery system, and unique size options, specifically engineered to manage challenging cases. It retains the specialized coating that reduces the risk of artery re-blockage, consistent with other XIENCE stents. This stent benefits from an exceptional safety record, substantiated by over 120 clinical trials involving more than 120,000 patients._x000D_
_x000D_
#Coronary Stents Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys _x000D_
_x000D_
#View The Full Coronary Stents Market Report:#_x000D_
_x000D_
#Coronary Stents Market Global Footprint: Which Region Leads The Market?#_x000D_
North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.